Discontinuation report SUPREFACT DEPOT 2 MONTHS
Report ID | 228169 |
Drug Identification Number | 02228955 |
Brand name | SUPREFACT DEPOT 2 MONTHS |
Common or Proper name | buserelin acetate |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | BUSERELIN |
Strength(s) | 6.3MG |
Dosage form(s) | IMPLANT |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 applicator |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2024-11-01 |
Actual discontinuation date | |
Remaining supply date | 2024-10-31 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | The expiry date on the remaining lot available is Oct.2024 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-06-19 | French | Compare |
v5 | 2024-06-19 | English | Compare |
v4 | 2024-06-03 | English | Compare |
v3 | 2024-05-16 | French | Compare |
v2 | 2024-05-16 | English | Compare |
v1 | 2024-05-16 | English | Compare |
Showing 1 to 6 of 6